IL15 and central nervous system cancer: In contrast, when IL-15 is continuously delivered to SE mice with micro-osmotic pumps from day 10 to 17 after glioma transplantation (50 ng ml−1, 100 μl, 0.5 μl h−1), a significant reduction in tumour size is observed (Fig. 4b).